Mediolanum International Funds Ltd Sells 201,770 Shares of Colgate-Palmolive (NYSE:CL)

Mediolanum International Funds Ltd reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 50.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 199,853 shares of the company’s stock after selling 201,770 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Colgate-Palmolive were worth $18,100,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Crews Bank & Trust acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $73,000. Busey Bank raised its stake in Colgate-Palmolive by 1.2% in the 4th quarter. Busey Bank now owns 167,988 shares of the company’s stock valued at $15,272,000 after acquiring an additional 2,073 shares during the period. Synergy Asset Management LLC acquired a new stake in Colgate-Palmolive during the 4th quarter valued at $49,000. Baader Bank Aktiengesellschaft boosted its position in Colgate-Palmolive by 50.3% during the fourth quarter. Baader Bank Aktiengesellschaft now owns 3,635 shares of the company’s stock worth $330,000 after purchasing an additional 1,217 shares during the period. Finally, Manning & Napier Advisors LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at $3,293,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 1.5 %

Shares of CL opened at $90.96 on Friday. The firm has a 50 day simple moving average of $91.58 and a two-hundred day simple moving average of $97.29. The company has a market cap of $74.31 billion, a P/E ratio of 26.06, a P/E/G ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.20%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CL shares. Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. UBS Group lowered their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $102.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.